Aspirin use and prostate tumor angiogenesis
Author:
Funder
National Institutes of Health
American Institute for Cancer Research
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10552-021-01501-6.pdf
Reference8 articles.
1. Mucci LA, Powolny A, Giovannucci E et al (2009) Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol 27(33):5627–5633
2. Liu Y, Chen JQ, Xie L et al (2014) Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis. BMC Med 12:55
3. Downer MK, Allard CB, Preston MA et al (2019) Aspirin use and lethal prostate cancer in the health professionals follow-up study. Eur Urol Oncol 2(2):126–134
4. Gupta S, Adhami VM, Subbarayan M et al (2004) Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 64(9):3334–3343
5. Liu XH, Kirschenbaum A, Yao S et al (2000) Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 164(3 Pt 1):820–825
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention;Cancer Prevention Research;2024-05-07
2. Causal relationship between prostate cancer and cardiovascular diseases: Univariable and multivariable Mendelian randomization;2024-02-23
3. Impact of genetically predicted atrial fibrillation on cancer risks: A large cardio-oncology Mendelian randomization study using UK biobank;Frontiers in Cardiovascular Medicine;2023-01-05
4. Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome;Cancers;2022-03-23
5. Longitudinal trajectories of lifetime body shape and prostate cancer angiogenesis;European Journal of Epidemiology;2022-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3